Class ITerminated · reported 2025-04-30

Zaarah Herbals brand Bhringraj Powder; packaged in 100g clear jars with gold lids; UPC…

NEW YORK WHOLESALE GROUP recalled this product and the FDA reported the enforcement action on 30 April 2025 as Class I. The recall was initiated by the firm. Products contain elevated levels of Lead (Pb): 3.231 ppm and Arsenic (As): 0.958 ppm;

The record

Every field below is published by the FDA in the openFDA food enforcement database. Check the FDA notice before acting on any recall: this page is a reading of the public record, not a substitute for it.

Product
Zaarah Herbals brand Bhringraj Powder; packaged in 100g clear jars with gold lids; UPC: 6 35028 99973 1
UPC
635028999731
Reason for recall
Products contain elevated levels of Lead (Pb): 3.231 ppm and Arsenic (As): 0.958 ppm;
Firm location
Hicksville, New York, United States
Classification
Class I
Status
Terminated
Recall number
F-0721-2025
Quantity
46.98 cases total
Distribution
NY, CT, NJ, CA
Initiated
10 March 2025
Reported by FDA
30 April 2025
Terminated
21 July 2026
Firm notified by
Press Release
Product codes
Batch No: BJ 04 Mfd. Date: July / 2022

Reading this record

Five things about this record are not in the record itself, and each one changes how it should be read.

  • Class I means the FDA judged a reasonable probability that the product would cause serious health consequences or death. The class is assigned by an agency health hazard evaluation under 21 CFR 7.41, not by the firm.
  • The firm started this recall itself. Most FDA food recalls are voluntary, and a recall is a food safety plan working rather than failing. The circumstances in which the agency asks for one instead are set out in 21 CFR 7.45.
  • This is one of 4 records covering the same recall event. The FDA opens one enforcement record per product code, so a recall of a product line appears here many times. Counting these records as 4 separate recalls, which almost every published figure does, overstates it by a factor of 4. All 4 of them are listed on this page.
  • The recall ran for 16 months, from 10 March 2025 to termination on 21 July 2026. Termination means the agency judged that all reasonable effort had been made, under 21 CFR 7.55, and it says nothing about whether product remained in circulation.
  • The distribution pattern names 4 states, and the FDA published the enforcement report 7 weeks after the firm began the recall.
  • Recalls of a dietary supplement run a median of 15 months, so this one was about typical for its category. Dietary supplements are regulated under their own good manufacturing practice rule, 21 CFR part 111, and they are the only food category where the dominant recall reason is an ingredient that was never declared because it is a pharmaceutical.

Named in the distribution pattern: New York, Connecticut, New Jersey, California. Those pages count recalls by where the RECALLING FIRM sits, which is a different question from where this product went.

What this recall was for

Chemical contamination

A chemical contamination recall covers a substance that is harmful in food and was never meant to be there: a heavy metal, a cleaning chemical, a pesticide residue, or a natural toxin such as aflatoxin or histamine.

A preventive controls plan covers chemical contamination under the clauses below. This is where the control belongs, not a finding against any firm named on this page: a recall record states a reason, and most of these recalls were initiated by the firm itself.

21 CFR 117.35(b)
Substances used in cleaning and sanitizing: toxic materials stored, identified and used so they cannot contaminate food, food-contact surfaces or packaging.
21 CFR 117 subpart G
Supply-chain programme: the approval and verification a receiving facility runs on a supplier when the hazard is controlled before the ingredient arrives.
21 CFR 117.130(b)(1)(ii)
Hazard analysis: identifying the known or reasonably foreseeable chemical hazards, including radiological hazards, pesticide and drug residues, natural toxins and food decomposition.

Filed under dietary supplements. A product can sit in more than one.

Every product in this recall

The FDA opened 4 enforcement records for this one recall, one per product code. This page carries all of them; the 3 below each have their own page with that product’s lot codes and distribution, and search engines are pointed here for the recall as a whole.

The other 3 records of FDA event 96420
ReportedProductFirmReasonClass
2025-04-30Zaarah Herbals brand Gurmar Powder; packaged in 100g clear jars with gold lids; UPC: 6 35028 99969 4NEW YORK WHOLESALE GROUPProducts contain elevated levels of Lead (Pb): 3.688 ppmClass I
2025-04-30Zaarah Herbals brand Vasaka Powder; packaged in 100g clear jars with gold lids; UPC: 6 35028 99967 0NEW YORK WHOLESALE GROUPProducts contain elevated levels of Lead (Pb): 6.504 ppmClass I
2025-04-30Zaarah Herbals brand Rasayan Churan; packaged in 100g clear jars with gold lids; UPC:6 35028 99966 3NEW YORK WHOLESALE GROUPProducts contain elevated levels of Lead (Pb): 88.038 ppmClass I

Other dietary supplements recalls for the same reason

These are the closest records in the corpus: the same kind of food, recalled for a hazard this record also names. Unlike the firm’s own records below, they come from different companies, which is what makes them a pattern rather than a history.

ReportedProductFirmReasonClass
2026-05-27Liposomal Sleep Spray. Dosage: 6 sprays Liquid. Packaging: Aluminum bottle. 30 ml. Firm Address: VitaminAlly LLC Chandler, AZ 85225Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II
2026-05-27Liposomal B12 Spray. Dosage: 3 sprays Liquid. Packaging: Aluminum bottle. 30 ml. Firm Address: VitaminAlly LLC Chandler, AZ 85225Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II
2026-05-27Liposomal Kids Liquid Multivitamin Drops. Dosage: 3mL Liquid. Packaging: Aluminum bottle. 90 ml. Firm Address: Vitaminally LLC Chandler, AZ 85225Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II
2026-05-27Liposomal Mens 50+ Liquid Multivitamin Drops. Dosage: 3mL Liquid. Packaging: Aluminum bottle. 90 ml. Firm Address: Vitaminally LLC Chandler, AZ 85225.Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II
2026-05-27Liposomal Prenatal+Postnatal Liquid Multivitamin Drops - Iron Free. Dosage: 3mL Liquid. Packaging: Aluminum bottle. 90 ml. Firm Address: Vitaminally LLC Chandler, AZ 85225Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II
2026-05-27Liposomal Collagen Booster. Dosage: 3mL Liquid. Packaging: Aluminum bottle. 90 ml. Firm Address: Vitaminally LLC Chandler, AZ 85225.Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II
2026-05-27Liposomal Women's Liquid Multivitamin Drops with Iron. Dosage: 3mL Liquid. Packaging: Aluminum bottle. 90 ml. Firm Address: Vitaminally LLC Chandler, AZ 85225.Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II
2026-05-27Liposomal D3+B12 Spray. Dosage: 3 sprays Liquid. Packaging: Aluminum bottle. 30 ml. Firm Address: VitaminAlly LLC Chandler, AZ 85225.Wellnov Supplements LLCDeviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.Class II

Other records from NEW YORK WHOLESALE GROUP

The FDA opens one enforcement record per product code, so several of these are frequently one recall event.

All 5 records for NEW YORK WHOLESALE GROUP

All 2025 recalls · All FDA food recall data

21 CFR 117.35(b) is the clause behind this recall, and it is one somebody has to produce evidence for at their next audit. Krolda maps supplier documents to the clause they satisfy in FSSC 22000, IFS Food and 21 CFR 117, and routes the corrective action when the evidence is missing.

Early access

Recall records come from the openFDA food enforcement API, published by the U.S. Food and Drug Administration in the public domain. Krolda adds the hazard classification and the clause mapping; neither is an FDA determination. Always check the FDA notice before acting on a recall.